Stockscreener 앱 받기
49.28
25.79%
-17.13
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path - MSN
Hims & Hers falls, Novo Nordisk rises after FDA says Ozempic shortage is over - Sherwood News
Hims & Hers shares dive on end of weight loss drug shortage - Yahoo Finance
U.S. Markets Dropped Friday; Hims & Hers Health Fell Furthest - Barron's
Hims & Hers Stock Plummets. The Wegovy Shortage Is Over. - Barron's
Hims & Hers Stock Falls as FDA Resolves Semaglutide ShortageNews and Statistics - IndexBox, Inc.
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today - Yahoo Finance
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers - Fortune
Why Hims & Hers Health Stock Is Plummeting Today - Yahoo Finance
Why Hims & Hers Stock Dropped Today - MSN
Why Hims & Hers Health Stock Is Skyrocketing Today - AOL
Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition - MSN
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock. - MarketWatch
Piper Sandler maintains Neutral on Hims & Hers stock, target at $24 - Investing.com India
Sector Update: Health Care - TradingView
Hims & Hers Buys Lab to Expand Into At-Home Blood Testing - MSN
Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday? - MSN
Why Is HIMS Stock Dropping Today? - Markets Insider
Hims & Hers' stock plunges as semaglutide shortage ends - Modern Healthcare
UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More Movers - Barron's
Analysts explain why Hims & Hers stock is crashing today - Investing.com
Hims and Hers Stock Drops Weight as Earnings Loom - Schaeffers Research
What's Going On With Hims & Hers Health Stock Today? - Benzinga
Why Novo Nordisk Stock Popped on Friday - The Motley Fool
BofA keeps Hims & Hers stock underperform, $21 target - Investing.com
Hims & Hers: A Glorious Opportunity To Trim (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Falls 19% Following FDA Update on Ozempic and Wegovy - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizes - Seeking Alpha
Hims & Hers Crashes 22%--But Its Secret Power Move Could Change Everything - Yahoo Finance UK
Hims & Hers acquires peptide facility to boost drug manufacturing - Modern Healthcare
Hims & Hers Health Shares Fall Pre-Bell as US FDA Says Ozempic, Wegovy Shortages Have Ended - Marketscreener.com
Hims & Hers Health Acquires California Peptide Facility -February 21, 2025 at 09:40 am EST - Marketscreener.com
Hims & Hers Health stock falls as FDA ends drug shortage - Investing.com
Hims & Hers acquires California peptide facility - Investing.com India
Hims & Hers gains peptide facility; shares tumble on semaglutide shortage end (HIMS:NYSE) - Seeking Alpha
Hims & Hers stock falls as Ozempic shortage ends (HIMS:NYSE) - Seeking Alpha
Hims & Hers Acquires US-Based Peptide Facility -February 21, 2025 at 09:02 am EST - Marketscreener.com
Why Hims & Hers Health (HIMS) Is Rallying Today - MSN
Hims & Hers Acquires US-based Peptide Facility - Joplin Globe
Hims Expands Drug Manufacturing With California Peptide Plant Acquisition - Bloomberg
Hims & Hers downgraded at Morgan Stanley on recent rally - MSN
Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided - MSN
Bank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup - Quartz
Hims & Hers: From Viral Ad to Volatile Stock - MSN
Hims & Hers: After A 205% Gain, Downgrading To A Hold, But Options Present An Opportunity - Seeking Alpha
Hims & Hers Health's chief commercial officer sells $444,450 in stock - Investing.com
Hims & Hers health chief legal officer sells $251,984 in stock - Investing.com
Unlocking HIMS Stock’s Secrets: How Innovations Propel a Surprise Surge - Reporteros del Sur -
Hims & Hers CEO Andrew Dudum sells $10.2 million in stock - Investing.com India
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,152 Shares - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading Down 5.9%Here's Why - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 128,127 Shares - MarketBeat
Recent Insider Transactions at Hims & Hers Health - TradingView
Hims & Hers Earnings Could Be a Game Changer-What to Do Now - MSN
Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition - Markets Insider
Hims & Hers Acquires US-based Peptide Facility -February 21, 2025 at 09:02 am EST - Marketscreener.com
Hims & Hers Health: The Ultimate Pick For The Next Decade (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Jumps 17.5% After Acquiring At-Home Lab Testing Facility - GuruFocus.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownHere's Why - MarketBeat
Market Whales and Their Recent Bets on HIMS Options - Benzinga
Hims & Hers to introduce at-home lab testing with Trybe Labs acquisition - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Given New $21.00 Price Target at Bank of America - MarketBeat
BofA lifts Hims & Hers stock target to $21, maintains underperform - Investing.com India
Social Buzz: Wallstreetbets Stocks Mixed Premarket Thursday; Hims & Hers Health to Advance, Carvana to Decline - Marketscreener.com
Hims & Hers Health (HIMS) to Release Quarterly Earnings on Monday - MarketBeat
1.06%
자본화:
|
볼륨(24시간):